«Candida albicans triggers a differential profile of microRNAs depending on its growing form» – Virulence – Enero 2017 – Carlos Del Fresno Sánchez 1 Abstract No abstract available Read more Categorías: Publications, Trained ImmunityPor Carlos del Fresnoenero 2, 2017Deja un comentarioEtiquetas: Candida albicansdectin-1macrophagemicroRNA.Navegación entre publicacionesAnteriorPublicación anterior:SHIP-1 Couples to the Dectin-1 hemITAM and Selectively Modulates Reactive Oxygen Species Production in Dendritic Cells in Response to Candida albicansSiguientePublicación siguiente:Neutrophils acROSs the Enemy LinesRelated PostsEndotoxin tolerance and trained immunity: breaking down immunological memory barriersmayo 1, 2024Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studymayo 15, 2022
Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studymayo 15, 2022
